Full video transcriptClick to expand
Auto-generated transcript of @cococolaah's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Week 3 update and I think it's an obsession at this point. I love this stuff. I think honestly it's probably my second favorite peptide I've ever taken
- 0:09Drizz up tide being number one
- 0:11but I feel so good and it's sustained I take it three times a week and I
- 0:17Feel it not just on the day of injecting it, but I do notice a difference throughout the days
- 0:22Keep in mind. I'm 35. I'm a single mom. I work a crazy job in tech
- 0:26I'm dealing with depression and grief and ADHD. So I think maybe naturally my my NAD levels are low
- 0:34So I'm feeling the the effects of this. It's so good. I can't wait to finish this course
- 0:42Because honestly like the results have just been really wonderful like I feel like this is a game changer for me
NAD+ for burnout and depression: what the science says
Quick answer
The creator is using injectable NAD+ three times weekly while managing self-reported depression, grief, and ADHD, conditions associated with mitochondrial stress and potentially reduced intracellular NAD+ availability. Her subjective improvement at week three is consistent with anecdotal reports in depleted individuals, but injected NAD+ lacks robust randomized controlled trial data for mood or energy endpoints outside addiction medicine contexts. Any NAD+ protocol for mental health adjacent conditions should be supervised by a licensed clinician and used alongside, not instead of, evidence-based psychiatric care.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For NAD+ for burnout and depression: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "NAD+ for burnout and depression: what the science says" from CocoColaah. We read the clip as a Peptide social video fact-checks claim about NAD+ Peptide Complex, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is using injectable NAD+ three times weekly while managing self-reported depression, grief, and ADHD, conditions associated with mitochondrial stress and potentially reduced intracellular NAD+ availability.
The reason this review is not generic is the source wording and the canonical claim label "peptides nad week 3 update it s an obsession at this point why was i." In this clip, the useful excerpt is: "Week 3 update and I think it's an obsession at this point." That wording changes the review because it points to NAD+ Peptide Complex safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. NAD+ Peptide Complex still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator is using injectable NAD+ three times weekly while managing self-reported depression, grief, and ADHD, conditions associated with mitochondrial stress and potentially reduced intracellular NAD+ availability.
FormBlends verdict
NAD+ Peptide Complex safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is using injectable NAD+ three times weekly while managing self-reported depression, grief, and ADHD, conditions associated with mitochondrial stress and potentially reduced intracellular NAD+ availability. Her subjective improvement at week three is consistent with anecdotal reports in depleted individuals, but injected NAD+ lacks robust randomized controlled trial data for mood or energy endpoints outside addiction medicine contexts. Any NAD+ protocol for mental health adjacent conditions should be supervised by a licensed clinician and used alongside, not instead of, evidence-based psychiatric care.
- NAD+ is a coenzyme, not a peptide. The distinction matters because the mechanisms, research literature, and regulatory pathways for peptides and coenzymes are different.
- Most human NAD+ research uses oral precursors like NMN or NR, not direct injection. Yoshino et al. (2021, Science) showed NMN raised tissue NAD+ and improved metabolic markers in women, but mood and energy were not primary endpoints.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- NAD+ is a coenzyme, not a peptide. The distinction matters because the mechanisms, research literature, and regulatory pathways for peptides and coenzymes are different.
- Most human NAD+ research uses oral precursors like NMN or NR, not direct injection. Yoshino et al. (2021, Science) showed NMN raised tissue NAD+ and improved metabolic markers in women, but mood and energy were not primary endpoints.
- Injected NAD+ has the most clinical data in addiction and withdrawal settings, not general wellness or mood optimization. Generalizing from those populations to burnout is a significant leap.
- Chronic stress, poor sleep, and depression are plausibly associated with lower NAD+ availability, which means depleted individuals may experience more subjective effect than healthy controls, but this has not been confirmed in controlled trials.
- Common side effects of NAD+ infusion or injection include flushing, nausea, and chest tightness, and these are more likely with faster administration rates. Anyone starting a protocol should discuss these with their prescribing clinician.
- Three weeks of subjective improvement cannot establish causation. Placebo response in open-label wellness protocols consistently runs 20 to 40 percent in studies, and emotional recovery from burnout can occur independently of any intervention.
- NAD+ is not a replacement for evidence-based depression treatment. If depression is a factor, a licensed mental health provider should be part of the care team regardless of what adjunctive protocols are being used.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @cococolaah actually say?
At week three of NAD+ injections, she called it her "second favorite peptide" and said she "feels it not just on the day of injecting it." She's dosing three times a week and connecting the benefits to her baseline burnout, describing herself as someone dealing with "depression and grief and ADHD" who suspects her NAD levels are naturally depleted. The core claim is simple: sustained energy and mood improvement from a course of NAD+ injections.
She's not claiming a cure. She's not prescribing a dose. She's reporting a personal experience against a specific backdrop of stress, grief, and neurodivergence. That context actually matters when evaluating whether her experience is plausible, and to her credit, she provided it unprompted.
Does the science back this up?
Partially, and the partial part is more interesting than a flat yes or no. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function. The idea that supplementing it improves energy and mood isn't wild, but the human evidence for injected NAD+ specifically is thin.
Most of the credible work focuses on NAD+ precursors, particularly NMN and NR, taken orally. Yoshino et al. (2021, Science) showed NMN supplementation improved muscle insulin sensitivity in postmenopausal women, suggesting NAD+ precursors can raise tissue NAD+ levels. A study by Conze et al. (2019, Scientific Reports) confirmed NR raises blood NAD+ in healthy adults. What it doesn't show is that raising NAD+ reliably translates to subjective energy or mood gains in people who aren't metabolically impaired.
For IV or injected NAD+, the published clinical literature is sparse. Most citations you'll find reference addiction and withdrawal settings, not general wellness or mood optimization. The gap between "NAD+ is important to cells" and "injecting NAD+ will make you feel better" is real, and it's wider than most TikTok content acknowledges.
What did they get wrong (or right)?
She got the self-awareness right. Framing her response as potentially amplified because "naturally my NAD levels are low" is actually a reasonable hypothesis. Chronic stress, sleep disruption, alcohol, and depression have all been associated with lower NAD+ availability. If she's genuinely depleted, she has more room to feel an effect than a healthy 25-year-old would.
What she got wrong, or at least glossed over, is calling NAD+ a peptide. It isn't. NAD+ is a coenzyme, not a peptide. Peptides are short chains of amino acids. Lumping NAD+ into peptide content is a common categorization error on wellness platforms and it muddies how people research and evaluate these compounds.
She also attributes the mood lift partly to NAD+ without accounting for placebo, behavioral change, or the natural regression that comes after bottoming out emotionally. Three weeks is not enough time to separate those signals. That doesn't mean her experience isn't real to her. It means she can't yet know why it's happening.
What should you actually know?
NAD+ injection protocols are not FDA-approved for depression, ADHD, grief, or energy optimization. They're used off-label, typically through telehealth providers, and the side effect profile for injected NAD+ includes flushing, nausea, and chest tightness, particularly with faster administration. These aren't rare, and they're worth knowing before you start.
The "course" framing she uses is appropriate. NAD+ is not meant to be a permanent daily supplement in injectable form, and reputable providers structure it as a defined protocol, not an indefinite regimen. Anyone considering this should be evaluated by a licensed clinician who can assess baseline metabolic and mental health status before prescribing.
The honest answer is that for people who are genuinely depleted from chronic stress, burnout, or certain health conditions, there is a plausible biological mechanism for why NAD+ support could help. But "plausible mechanism" and "proven treatment" are not the same thing. If you're struggling with depression, NAD+ is not a substitute for evidence-based mental health care.
Bottom line
Her experience sounds real, and her reasoning is more grounded than most NAD+ content on TikTok. But three weeks of subjective improvement is not proof, NAD+ is not a peptide, and the clinical evidence for injected NAD+ in mood or energy disorders is genuinely limited. The enthusiasm is understandable. The extrapolation needs to stop there.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
CocoColaah · TikTok creator
89.9K views on this video
NAD+ week 3 update - It’s an obsession at this point! Why was i sleeping on this for so long? Also I think it’s working because i’m burned out from everything in life but it’s giving me my spark back. #nad #nad+ #singlemom #depression
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about nad+?
NAD+ is a coenzyme, not a peptide. The distinction matters because the mechanisms, research literature, and regulatory pathways for peptides and coenzymes are different.
What does the video say about most human nad+ research uses?
Most human NAD+ research uses oral precursors like NMN or NR, not direct injection. Yoshino et al. (2021, Science) showed NMN raised tissue NAD+ and improved metabolic markers in women, but mood and energy were not primary endpoints.
What does the video say about injected nad+ has the most clinical data in addiction?
Injected NAD+ has the most clinical data in addiction and withdrawal settings, not general wellness or mood optimization. Generalizing from those populations to burnout is a significant leap.
What does the video say about chronic stress, poor sleep,?
Chronic stress, poor sleep, and depression are plausibly associated with lower NAD+ availability, which means depleted individuals may experience more subjective effect than healthy controls, but this has not been confirmed in controlled trials.
What does the video say about common side effects of nad+ infusion?
Common side effects of NAD+ infusion or injection include flushing, nausea, and chest tightness, and these are more likely with faster administration rates. Anyone starting a protocol should discuss these with their prescribing clinician.
What does the video say about three weeks of subjective improvement cannot establish causation. placebo response?
Three weeks of subjective improvement cannot establish causation. Placebo response in open-label wellness protocols consistently runs 20 to 40 percent in studies, and emotional recovery from burnout can occur independently of any intervention.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by CocoColaah, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.